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OBJECTIVES The goal of this study was to determine the relationship between resting blood pressure (BP)
and C-reactive protein (CRP) in a multi-ethnic cohort of men and women from the
Multi-Ethnic Study of Atherosclerosis (MESA).
BACKGROUND Several investigators have observed elevated levels of CRP in individuals with hypertension.
Hypertension prevalence varies considerably across ethnic groups. Important questions
remain regarding whether the relationship between hypertension and CRP is similar across
ethnic and gender subgroups.
METHODS The MESA participants had CRP levels determined at the baseline clinical examination
(N  6,814). Hypertension, treated as a dichotomous variable (yes/no), was defined as a
systolic or diastolic BP 140/90 mm Hg or a self-reported history of hypertension and use
of antihypertensive medications.
RESULTS The geometric mean CRP in hypertensive participants was 2.3  0.07 mg/l compared with 1.6
 0.07 mg/l among normotensive participants (p 0.0001). The relative difference in CRP levels
in hypertensives compared with normotensives was similar regardless of gender (13% in men and
13% in women). Ethnic comparisons showed that Chinese participants had the lowest CRP
concentration but the largest difference in CRP by hypertension status (24%). Caucasians and
African Americans had 10% to 15% higher CRP levels with hypertension, whereas Hispanics had
no significant difference in CRP by hypertension status.
CONCLUSIONS This study confirms the existence of an independent association between hypertension and
inflammation in both men and women. Ethnic group differences were evident, with the
strongest association observed in Chinese participants and no difference in CRP levels by
hypertension status in Hispanics. (J Am Coll Cardiol 2005;46:1869–74) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.050American College of Cardiology Foundation
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typertension is an important modifiable risk factor con-
ributing to an increased risk of myocardial infarction (MI)
orldwide (1). Despite the longstanding recognition of
n association between hypertension and MI, the precise
echanisms that account for this relationship remain un-
lear. Multiple substudies of large clinical trials have found
hat higher C-reactive protein (CRP) concentrations are
ssociated with worse outcomes in patients with unstable
oronary disease (2–4). Recently, several investigators have
bserved higher CRP concentrations in individuals with
ypertension (5–7). This raises the possibility that higher
RP, or subclinical inflammation as indicated by CRP, may
e one of the causal mechanisms contributing to an in-
reased risk for MI in hypertensive patients.
Although there have been several large studies looking at
he association between hypertension and CRP, most par-
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ccepted July 18, 2005.icipants have been Caucasian, potentially limiting the
eneralizability of results (5,6,8). Hypertension varies con-
iderably across ethnic groups, with the highest rates among
frican-American women (9). In addition, CRP levels
iffer by ethnicity (10,11). It is not known whether the
elationship between CRP and hypertension is present
cross multiple ethnic groups. A consistent pattern across
thnicity would provide additional evidence that the ob-
erved association reflects a fundamental feature of human
iology and is not simply attributable to confounding by
nmeasured factors that are common in Caucasian
ndividuals.
In the present study, our primary goal was to determine
hether there was an association between hypertension and
RP among a multi-ethnic group of men and women ages
5 to 84 years old enrolled in the Multi-Ethnic Study of
therosclerosis (MESA). A secondary goal was to ascertain
hether gender and ethnicity modify the relationship be-
ween hypertension and CRP.
ETHODS
he MESA study was initiated in July 2000 to investigate
he prevalence, correlates, and progression of subclinical
ardiovascular disease in individuals without known cardio-
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BP and CRP in MESA November 15, 2005:1869–74ascular disease (12). The cohort consisted of 6,814 men
nd women ages 45 to 84 years old recruited in six U.S.
ommunities. There are 47% men with an ethnic represen-
ation of 38% white, 28% African-American, 22% Hispanic,
nd 12% Asian (of Chinese descent) individuals.
History, measurements, and laboratory data for the
resent analysis were taken from the first examination of the
ESA cohort beginning in July 2000. Information about
ge, gender, ethnicity, medical history, and alcohol con-
umption was obtained by questionnaires. A history of
ypertension and the use of blood pressure (BP) medica-
ions for hypertension were obtained from medical history.
esting BP was taken three times in the seated position
fter a five-minute rest using a Dinamap model Pro 100
utomated oscillometric sphygmomanometer (Critikon,
ampa, Florida) (13) with the average of the last two
easurements recorded and verified. Diabetes was defined
s normal, impaired fasting glucose, or diabetes based on
997 American Diabetes Association guidelines (14).
moking was defined as never, current, or former. Body
ass index was derived from the equation weight (kg)/
eight (m2). Physical activity was defined as total of all light,
oderate, and vigorous activities (min/week) multiplied by
ndividual metabolic equivalent values. The CRP was mea-
ured using the BNII nephelometer (N High Sensitivity
RP; Dade Behring Inc., Deerfield, Illinois) at the Labo-
atory for Clinical Biochemistry Research (University of
ermont, Burlington, Vermont). Analytical intra-assay co-
fficient of variations ranged from 2.3% to 4.4%, and
nter-assay coefficient of variation ranged from 2.1% to
.7%.
tatistical analysis. Hypertension, treated as a dichoto-
ous variable (yes/no), was defined as a systolic or diastolic
P 140/90 mm Hg or a self-reported history of hyper-
ension and current use of antihypertensive medications. In
econdary analyses, systolic BP, diastolic BP, and pulse
ressure were modeled as continuous variables. In addition,
ategories of BP defined by Seventh Report of the Joint
ational Committee on Prevention, Detection, Evaluation,
nd Treatment of High Blood Pressure (JNC 7) guidelines
120/80 mm Hg, 120 to 139/80 to 89 mm Hg,
140/90 mm Hg) (15) were also used when analyzing the
elationship between BP and CRP. The CRP as a contin-
Abbreviations and Acronyms
BP  blood pressure
CRP  C-reactive protein
HTN  hypertension
JNC 7  Seventh Report of the Joint National
Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood
Pressure
MESA  Multi-Ethnic Study of Atherosclerosis
MI  myocardial infarctionous variable was log-transformed to more closely reflect a wormal distribution for the statistical analysis. The geomet-
ic mean of CRP and its geometric mean standard error
ere used for tabular and graphical presentation. The
tandard error of CRP values was estimated for the back-
ransformed data using a delta method approximation.
Differences in baseline characteristics by hypertension
tatus were determined by chi-square and t tests. Linear
egression modeling was used to determine the relationship
etween the outcome variable, CRP, and hypertension
HTN) in univariable and multivariable models and after
tratifying by gender and ethnicity. The multivariable anal-
sis included the following covariates: age, ethnicity, gender,
linic site, body mass index, low-density lipoprotein and
igh-density lipoprotein cholesterol, diabetes, smoking, al-
ohol consumption, use of HMG-CoA reductase inhibi-
ors, estrogen therapy, and aspirin. Similar linear models
ere used to determine the relationship between CRP and
ystolic BP, diastolic BP, or categories of BP by JNC 7
riteria after adjustment for the same covariates. For these
odels, participants on BP medications were excluded. The
nteraction terms, gender  HTN and ethnicity  HTN
ere tested separately in the full model. Logistic regression
odeling was used to determine the relative odds of
ypertension by category of CRP (1 mg/l, 1 to 3 mg/l,3
g/l) after stratifying by ethnicity in both an unadjusted and
n adjusted analysis. The Zhang-Yu method was used to
stimate the relative risk of hypertension from the calculated
dds ratio given the outcome, hypertension, was common
16). Statistical analyses were performed using SAS 9.0
oftware (SAS Institute Inc., Cary, North Carolina).
ESULTS
he cohort consisted of 6,814 individuals with an average
ge of 63 years. Table 1 shows differences in baseline
haracteristics stratified by the presence of hypertension.
articipants with hypertension were different from normo-
ensive individuals in every category listed in Table 1 except
or levels of high-density lipoprotein cholesterol. Adjust-
ents in the statistical models were made to account for
hese differences.
The geometric mean of CRP in hypertensive individuals
as 2.3  0.07 mg/l, compared with 1.6  0.07 mg/l
mong normotensive individuals (p  0.0001). After ad-
ustment for potential confounders, this difference remained
tatistically significant (2.5  0.1 mg/l vs. 2.2  0.1 mg/l, p
0.0001). In 4,225 participants not taking BP medications,
ystolic BP and pulse pressure, but not diastolic pressure,
ere associated with CRP in univariable (p  0.0001,
.0001, and 0.5, respectively) and multivariable models (p
.003, 0.002, and 0.2, respectively). When treating CRP as
categorical variable, mean systolic BP was 2 mm Hg
igher in those with CRP values 3 mg/l compared with
1 mg/l (124.2  0.8 mm Hg vs. 121.7  0.8 mm Hg, p
0.0001) after multivariable adjustment. When resting BPas categorized by JNC 7 criteria, individuals with BPs of

h

b
J
p
h
C
n
(
t
l
b
(
ensity
ation.
F
c
l
a
e
F
h
m
t
1871JACC Vol. 46, No. 10, 2005 Lakoski et al.
November 15, 2005:1869–74 BP and CRP in MESA120/80 mm Hg or between 120 to 139/80 to 89 mm Hg
ad significantly lower values than those with a BP of
140/90 mm Hg (Fig. 1). When testing for an association
etween CRP and systolic or diastolic BP, pulse pressure, or
NC 7 BP category, including participants on BP medications
roduced similar results.
Women had higher CRP levels than men in both
ypertensive categories (Fig. 2). The relative difference in
RP levels in hypertensive participants compared with
ormotensive participants was similar regardless of gender
Table 1. Baseline Characteristics of MESA Co
Hyp
(n
Gender
Male (%)
Female (%)
Race
Caucasian (%)
Asian (of Chinese descent) (%)
African American (%)
Hispanic (%)
Age (yrs, mean  SD) 6
Body mass index (mean  SD) 2
Alcohol use (%)
Never
Former
Current
Cigarette smoking (%)
Never
Former
Current
Diabetes, ADA fasting criteria (%)
No
Impaired
Yes
Medications
HMG-CoA reductase inhibitors (%)
Estrogens (%)
Aspirin (%)
LDL cholesterol (mg/dl), mean  SD 1
HDL cholesterol (mg/dl), mean  SD
ADA  American Diabetes Association; HDL  high-d
Multi-Ethnic Study of Atherosclerosis; SD  standard devi
igure 1. Adjusted levels of C-reactive protein (CRP) by blood pressure
ategory. Adjusted for age, gender, site, body mass index, low-density
ipoprotein and high-density lipoprotein cholesterol, diabetes, smoking,
lcohol consumption, physical activity, HMG-CoA reductase inhibitors,
strogen therapy, and aspirin.
C
n13% in men and 13% in women). Gender did not modify
he relationship between hypertension status and CRP
evels (p  0.81).
Chinese participants had the lowest CRP concentration,
ut the largest difference in CRP by hypertension status
1.54  0.21 mg/l vs. 1.91  0.25 mg/l, p  0.002) in fully
With and Without Hypertension
sion
093)
No Hypertension
(n  3,721) p Value
0.002
56.6
52.8
0.0001
61.4
61.2
39.8
58.0
10 59.8  10 0.0001
5 27.5  5 0.0001
0.0001
18.2
22.0
59.8
0.0001
50.2
34.9
14.8
0.0001
85.1
6.0
8.9
5.2 0.0001
7.0 0.01
10.7 0.0001
31 119  31 0.0001
15 51  15 0.27
lipoprotein; LDL  low-density lipoprotein; MESA 
igure 2. Adjusted differences in C-reactive protein (CRP) levels by
ypertension category in women and men. Adjusted for age, site, body
ass index, low-density lipoprotein and high-density lipoprotein choles-
erol, diabetes, smoking, alcohol consumption, physical activity, HMG-hort
erten
 3,
43.4
47.2
38.6
38.9
60.2
42.0
6.2 
9.4 
23.4
26.4
50.1
51.0
38.1
10.9
67.2
9.7
22.6
9.4
6.8
13.3
15 
51 oA reductase inhibitors, estrogen therapy, and aspirin. Open bars 
ormal; solid bars  hypertension.
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BP and CRP in MESA November 15, 2005:1869–74djusted models (Table 2). Other ethnic groups had differ-
nces in CRP between 10% and 15% by hypertension status,
xcept Hispanics, who had the highest CRP concentrations
ut no significant difference in CRP by hypertension.
imilar results were found when determining the risk of
ypertension by CRP category among different ethnic
roups. Table 3 shows the relative odds of hypertension by
ategory of CRP with the largest risk of hypertension
mong Chinese with CRP3 mg/l. Estimating the relative
isk from the calculated odds ratios did not change the
nterpretation of these results. These apparent ethnic dif-
erences in the relationship between CRP and hypertension
tatus were of borderline statistical significance when tested
or a formal interaction (p  0.09). Figure 3 depicts the
djusted mean CRP values by BP category (120/80 mm
g, 120 to 139/80 to 89 mm Hg, 140/90 mm Hg),
howing no statistical differences in any one ethnic group.
hen individuals on BP medications were not excluded, a
tatistical difference in CRP by BP category was evident in
hinese participants (p  0.02).
ISCUSSION
n the present study, hypertension was associated with
igher CRP levels in both men and women. Systolic BP and
ulse pressure, but not diastolic BP, were associated with
RP. The strength of the association varied across ethnic
roups, with the strongest association observed in Chinese
articipants and no difference in CRP levels by hypertension
tatus in Hispanic participants.
able 2. Unadjusted and Adjusted Mean C-Reactive Protein Levels
Unadjusted
Ethnic Group n
Normal
Mean (SE)
Hypertensio
Mean (SE)
aucasian 2,602 1.55 (.09) 2.18 (.14)
hinese 801 0.82 (.08) 1.20 (.14)
frican American 1,871 2.07 (.17) 2.76 (.17)
ispanic 1,488 2.24 (.15) 2.57 (.19)
Adjusted for age, gender, site, body mass index, low-density lipoprotein and high-den
nhibitors, estrogen therapy, and aspirin.
able 3. Relative Odds of Hypertension by Category of C-React
Ethnic Group CRP >3 vs. 1–3 mg/l Unadjust
aucasian 1.52 (1.25–1.86) 0
hinese 2.05 (1.50–2.80) 0
frican-American 1.15 (0.89–1.48) 0
ispanic 1.20 (0.90–1.58) 0
Adjuste
aucasian 1.10 (0.89–1.39) 0
hinese 1.70 (1.18–2.46) 0
frican-American 1.02 (0.77–1.34) 0
ispanic 1.09 (0.79–1.52) 0
Adjusted for age, gender, body mass index, low-density lipoprotein and high-densit
MG-CoA reductase inhibitors, estrogen therapy, and aspirin.
CRP  C-reactive protein.Previous studies have reported an association between BP
nd CRP. Blake et al. (5) showed an independent associa-
ion between CRP and BP in the Women’s Health Study
ohort. Increasing categories of BP were significant predic-
ors of CRP after adjustment for potential confounders.
ubsequent studies have confirmed an association between
RP and hypertension (6–8) except in a Spanish (17) and
Colombian population (18). In a study by Bautista et al.,
18) CRP did not increase risk of prevalent hypertension
mong Colombians when comparing those in the highest
uartile of CRP (5.2 mg/l) with those in the lowest
uartile of CRP (1.3 mg/l) (p  0.2).
Ethnic differences in the relationship between CRP and
ypertension were evident in the current study. Of partic-
lar interest was the large relative difference in CRP by
ypertension status in the Chinese participants, which was
ot apparent in the Hispanic population. There are three
ossible explanations for these ethnic differences. First,
ispanics may be exposed to some environmental, nutri-
ional, or intrinsic factor that competes with hypertension as
cause for elevated CRP, therefore masking an association
etween CRP and hypertension in the Hispanic population.
lternatively, a relationship between inflammation and
ypertension may not be present in Hispanics, as seen in
wo previous studies (17,18), suggesting that an inflamma-
ory mechanism related to hypertension varies by ethnicity.
astly, the relationship seen between CRP and hyperten-
ion in the Caucasian, Chinese, or African-American pop-
lations may be spurious because of residual confounding of
nmeasured variables related to ethnic-related differences in
thnic Group in Participants With and Without Hypertension
Adjusted*
p Value
Normal
Mean (SE)
Hypertension
Mean (SE) p Value
0.0001 2.13 (.16) 2.44 (.18) 0.002
0.0001 1.54 (.21) 1.91 (.25) 0.003
0.0001 2.45 (.23) 2.78 (.21) 0.01
0.02 2.76 (.22) 2.78 (.23) 0.88
oprotein cholesterol, diabetes, smoking, alcohol consumption, HMG-CoA reductase
rotein
Value CRP >3 vs. <1 mg/l Unadjusted p Value
1.97 (1.62–2.41) 0.0001
2.12 (1.36–3.29) 0.009
1.75 (1.38–2.22) 0.0001
1.44 (1.09–1.90) 0.009
alue Adjusted p Value
1.28 (1.0–1.65) 0.05
1.82 (1.09–3.04) 0.02
1.42 (1.07–1.90) 0.01
1.21 (0.86–1.70) 0.27
protein cholesterol, diabetes, physical activity smoking, alcohol consumption, use ofby E
nive P
ed p
.0001
.0001
.28
.23
d* p V
.36
.004
.9
.57
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November 15, 2005:1869–74 BP and CRP in MESAiet, air pollution, family crowding, and so on. Future
ESA studies may be able to clarify these questions.
There are a number of plausible mechanisms that could
xplain an association between CRP and hypertension. Wang
t al. (19) showed that CRP independently up-regulates
ngiotensin II type 1 receptors in smooth muscle cells. CRP,
cting through the angiotensin II type 1 receptors, could
heoretically result in subsequent elevation in BP. Conversely,
n vitro studies indicate that hypertension can stimulate the
elease of inflammatory cytokines secondary to biomechanical
ctivation (20), up-regulation of monocyte chemoattractant
rotein-1 (20), and generation of reactive oxygen species (21).
hus, the causal direction in the relationship between inflam-
ation and hypertension is unclear and could even be bidirec-
ional. Whether these mechanisms differ by ethnicity is un-
nown.
There are several limitations to the current study. This is a
ross-sectional study, thus the temporal relationship between
levations in CRP and development of hypertension cannot be
nferred. Secondly, unmeasured variables related to either BP
nd/or CRP may confound an association between inflamma-
ion and hypertension. Finally, isolated resting BPs may be an
ncomplete reflection of an individual’s daily BP exposure.
In summary, we report a significant association between
RP levels and hypertension. This was evident when systolic
P or pulse pressure, but not diastolic BP, was the indepen-
ent variable of interest. The higher CRP levels by hyperten-
ion status were present in both men and women. Some ethnic
roup differences were observed, with a greater association
mong Chinese participants and no difference in CRP values
y hypertension status in Hispanic participants. Although
tudies have shown that CRP levels vary by ethnicity and
ypertension prevalence differs by ethnic group, no previous
igure 3. Adjusted C-reactive protein (CRP) levels by blood pressure
ategory stratified by ethnicity. Adjusted for age, gender, body mass index,
ow-density lipoprotein and high-density lipoprotein cholesterol, diabetes,
moking, physical activity, alcohol consumption, HMG-CoA reductase
nhibitors, estrogen therapy, and aspirin. Diamonds  Caucasian; squares
Chinese; triangles  Hispanic; circles  African American.tudies have examined whether the relationship between in-
1ammation and hypertension was preserved across multiple
thnic groups. Thus, the current study presents new data
oncerning the association between inflammation and hyper-
ension in a multi-ethnic cohort, and provides a stimulus to
nderstand whether a causal relationship between CRP and
ypertension is truly present and preserved across ethnic
roups. Understanding the cause for the association between
RP and hypertension, as well as the explanation for ethnic
ariation in this relationship, may provide new insight into the
athogenesis of hypertension and the role of inflammation in
ascular disease.
eprint requests and correspondence: Dr. Susan G. Lakoski,
ivision of Internal Medicine/Cardiology, Medical Center Bou-
evard, Winston-Salem, North Carolina 27157. E-mail: slakoski@
fubmc.edu.
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